Illiasul Ibad/X
Aug 24, 2025, 18:21
Illiasul Ibad: How Clinical Trials Revolutionized ANCA Vasculitis Treatment from Cyclophosphamide to Rituximab
Illiasul Ibad, Rheumatologist at Christian Medical College, Vellore, shared a post on X:
“How clinical trials revolutionized ANCA vasculitis maintenance – from cyclophosphamide to rituximab, this is the journey of evidence, one trial at a time.
Facts. Timelines. Game-changers.
A must-read for every physician, rheumatologist, nephrologist, pulmonologist, and ophthalmologist. This is how science shaped the standard of care.
Special thanks to George Deva Raja for the image design.”
Stay updated with Hemostasis Today.
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together